Drug
Gsk561679 OR
Gsk561679 OR: highest development phase Phase 1, developed by GlaxoSmithKline. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- GlaxoSmithKline
Trials
| Drug | Phase | Indication |
|---|---|---|
| GSK561679 tablet or solution NCT00539136 | Phase 1 | Healthy Subjects |
Latest
No recent events.
Follow Gsk561679 OR on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.